Eurofins Nine-Month Organic Revenue Rises 3.0%; Cuts Fiscal 2026 Organic Growth Outlook

Eurofins Scientific (EUFI.PA, ERF.PA) reported nine-month revenue of 5.614 billion euros, up 3.7% year over year, with organic growth of 3.0% for the period. Third-quarter organic growth reached 3.5%. The company lowered its fiscal 2026 organic growth guidance, now expected below its prior mid-single-digit objective. Profitability and cash-flow targets for fiscal 2026 were unchanged, and Eurofins reaffirmed its mid-term and fiscal 2027 objectives first confirmed at its first-half results presentation. Shares last traded at 79.00 euros on Euronext Paris.